Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort
18 October 2023 - 1:00AM
Invizyne Technologies, Inc., a leading designer of
enzyme-based biomanufacturing systems – and a subsidiary of
MDB Capital Holdings, LLC, (NASDAQ:MDBH) – today
announced it was one of four companies selected to participate in
the latest Shell Gamechanger Accelerator™ Powered by NREL (GCxN)
program.
“We’re honored to be selected by GCxN
and awarded $250,000 in non-dilutive funding to work with Shell and
the National Renewable Energy Laboratory on a technical assistance
project that will help us on our path to commercialization,” said
Mo Hayat, CEO of Invizyne. “I’d like to offer congrats to our
fellow promising cleantech companies selected for the sixth cohort
– DTE Materials, Hexas and ZILA Bioworks.”
GCxN is a multi-million dollar,
multi-year program developed in collaboration between Shell
GameChanger and the U.S. Department of Energy’s National Renewable
Energy Laboratory (NREL) working to identify and advance the
next generation of transformative technologies with the potential
to dramatically alter the future global energy landscape. GCxN
provides selected companies with access to technical experts and
state-of-the-art facilities to reduce technology development risk
and accelerate commercialization of new cleaner technologies.
The companies selected for the sixth
cohort are focused on developing innovative technologies that
sequester carbon into building materials and convert waste and/or
bio-renewable feedstocks to desired energy and chemical
products.
With its patented SimplePath™
technology platform, Invizyne believes it has developed a new way
to make valuable chemicals from plant-based energy sources that are
both energy-efficient and economically competitive.
"In this cohort, we're harnessing
NREL’s vast research capabilities to tackle some of today's
paramount sustainability challenges,” said Johanna Jamison, GCxN
Program Manager at NREL. “We're fostering collaborations in
unprecedented areas to advance cutting-edge cleaner technologies
with the potential to dramatically impact the future energy
landscape."
Hayat concluded, “Thanks to our unique
biomanufacturing technologies and ability to use renewable
feedstocks, we believe Invizyne could play a pivotal role in
creating sustainable fuels and chemical products that were
previously not commercially viable when made with traditional
cell-based synthetic biology. We’re thankful GCxN recognized this
potential for our cell-free approach and are excited to begin
working with the teams to accelerate our path to market.”
About GCxN
The Shell GameChanger Accelerator™ powered by NREL (GCxN) is a
multi-million dollar, multi-year program developed in collaboration
between Shell GameChanger and the U.S. Department of Energy’s
National Renewable Energy Laboratory (NREL) to discover and advance
emerging clean technologies with the potential to dramatically
alter the future global energy landscape. GCxN identifies promising
startup companies through an ecosystem of more than 60 cleantech
business incubators, accelerators, and universities, providing
access to $250,000 in non-dilutive funding per company to develop
and demonstrate new energy technologies. GCxN is made possible by
funding through Shell GameChanger. GCxN is administered by NREL,
located in Golden, Colo.
About Invizyne Technologies, Inc.
Invizyne, a subsidiary of MDB Capital Holdings,
LLC, (NASDAQ:MDBH) ("MDB") (www.mdb.com),
is an enzyme-based biomanufacturing technology company
headquartered in Monrovia, California. The company specializes in
designing enzymes and building truly cell-free enzymatic pathways
that can run continuously and unassisted outside of living cells,
therefore avoiding many of the problems other synthetic biology
companies run into when trying to scale cell-based or immobilized
biomanufacturing technologies. With a vision to enable a new
generation of natural resources, we believe Invizyne's enzyme
design capabilities, coupled with its patent protected
biomanufacturing technology platform, position the company to drive
positive change in the biofuels industry and many other industries
that are looking for greener and better manufacturing
technologies.
For more information, please visit www.invizyne.com
Media contacts: press@invizyne.comPartnership contacts:
partners@invizyne.com
Forward-Looking Statements
This press release contains "forward-looking
statements." These forward-looking statements are made as of the
date they were first issued and were based on current expectations,
estimates, forecasts and projections as well as the beliefs and
assumptions of management. Words such as "expect," "anticipate,"
"should," "believe," "hope," "target," "project," "goals,"
"estimate," "potential," "predict," "may," "will," "might,"
"could," "intend," "shall" and variations of these terms or the
negative of these terms and similar expressions are intended to
identify these forward-looking statements.
Forward-looking statements are subject to a
number of risks and uncertainties, many of which involve factors or
circumstances that are beyond Invizyne's control. Invizyne's actual
results could differ materially from those stated or implied in
forward-looking statements due to a number of factors. The
forward-looking statements included in this press release represent
Invizyne's views as of the date of this press release. Invizyne
anticipates that subsequent events and developments will cause its
views to change. Invizyne undertakes no intention or obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise. These
forward-looking statements should not be relied upon as
representing Invizyne's views as of any date subsequent to the date
of this press release.
MDB Capital (NASDAQ:MDBH)
Historical Stock Chart
From Apr 2024 to May 2024
MDB Capital (NASDAQ:MDBH)
Historical Stock Chart
From May 2023 to May 2024